{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:43:00Z","timestamp":1793400180519,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.intimp.2024.112274","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T21:14:35Z","timestamp":1716239675000},"page":"112274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-9944","authenticated-orcid":false,"given":"Jing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112274_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molmed.2010.11.001","article-title":"Inflammasomes and autoimmunity","volume":"17","author":"Shaw","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2024.112274_b0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coi.2012.12.004","article-title":"Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: Recent developments","volume":"25","author":"Haneklaus","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2024.112274_b0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112274_b0025","first-page":"12","article-title":"Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases","volume":"34","author":"Zhong","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112274_b0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.112274_b0035","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.30568","article-title":"The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis","volume":"63","author":"Artlett","year":"2011","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2024.112274_b0040","doi-asserted-by":"crossref","unstructured":"R.J. Mathews, J.I. Robinson, M. Battellino, C. Wong, J.C. Taylor, G. Biologics in Rheumatoid Arthritis, S. Genomics Study, S. Eyre, S.M. Churchman, A.G. Wilson, et al., Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann. Rheum. Dis. 2014; 73:1202\u20131210.","DOI":"10.1136\/annrheumdis-2013-203276"},{"key":"10.1016\/j.intimp.2024.112274_b0045","doi-asserted-by":"crossref","first-page":"e100361","DOI":"10.1371\/journal.pone.0100361","article-title":"Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome","volume":"9","author":"Sode","year":"2014","journal-title":"PLoS ONE."},{"key":"10.1016\/j.intimp.2024.112274_b0050","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4049\/jimmunol.1600659","article-title":"Hyperactivation of the NLRP3 Inflammasome in myeloid cells leads to severe organ damage in experimental lupus","volume":"198","author":"Lu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112274_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.112274_b0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease","volume":"27","author":"Masters","year":"2009","journal-title":"Annu. Rev. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692400794X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692400794X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:26:44Z","timestamp":1717655204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692400794X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":11,"alternative-id":["S156757692400794X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112274","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112274"}}